TCW AAA級CLO主動型ETF ACLO 深 滬
等待開盤 06-25 09:30:00 美东时间
50.45
+0.010
+0.02%
華盛通- 最 高50.47
- 今 開50.47
- 成交量 3983股
- 最 低 50.42
- 昨 收 50.44
- 總市值 4.99亿
- 52周最高 50.47
- 市盈率 靜 --
- 換手率 0.04%
- 52周最低 47.96
- 委 比 0.00%
- 總股本 990.00万
- 歷史最高 50.47
- 量 比 0.14
- 振 幅 0.10%
- 歷史最低 46.4599
- 每 手 1
- 風險率 0.74%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation
BRIEF-FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation May 27 (Reuters) - Ironwood Pharmaceuticals Inc IRWD.O : FDA APPROVES USE OF LINZESS® (LINACLOTIDE) IN PEDIATRIC PATIENTS TWO YEARS OF AGE AND OLDER WITH FUNCTIONAL CONSTIPATION (FC) IRONWOOD PHARMACE
05-27 22:35
BRIEF-FDA Approves Linzess Capsules For Children Aged 7 And Older With IBS With Constipation
Nov 5 (Reuters) - FDA: FDA: APPROVED LINZESS (LINACLOTIDE) CAPSULES FOR PEDIATRIC PATIENTS 7 YEARS AND OLDER WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION FDA: LINZESS RECOMMENDED DOSAGE FOR PEDIATR...
2025-11-06 02:31
